Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
Unidad de Gestión Clínica de Salud Mental, Hospital Regional Universitario de Málaga, Málaga, Spain.
Alcohol Res. 2022 May 19;42(1):09. doi: 10.35946/arcr.v42.1.09. eCollection 2022.
The endogenous cannabinoid system is involved in several physiological functions in the central nervous system including the modulation of brain reward circuitry and emotional homeostasis. Substantial evidence implicates brain endocannabinoid signaling in the processing of drug-induced reward states, wherein repeated exposure besets pathological changes in activity that contribute to the progression of alcohol use disorder. This review provides a narrative summary of recent studies exploring the interaction between alcohol exposure and changes in endocannabinoid signaling that may underlie the development of alcohol use disorder.
The authors began with an initial search for review articles to assist in the identification of relevant literature. This was followed by separate searches for primary literature and recent studies. The search terms "alcohol/ethanol" and "endocannabinoids" were applied, along with terms that covered specific objectives in reinforcement and addiction behavior. The content was further refined by excluding articles containing a broad focus on psychiatric disorders, polysubstance abuse, non-cannabinoid signaling lipids, and other criteria.
The initial search yielded a total of 49 review articles on PubMed, 13 on ScienceDirect, and 17 on Wiley Online, from which the authors garnered information from a total of 16 reviews. In addition to independent searches, this review provides information from a collection of 212 publications, including reviews and original research articles.
The review discusses the effects of alcohol consumption on brain endocannabinoid signaling, including alcohol-based perturbations in endocannabinoid-mediated synaptic transmission, the modulation of alcohol-related behaviors by manipulating signaling elements of the endocannabinoid system, and the influence of dysregulated endocannabinoid function in promoting withdrawal-induced anxiety-like behavior. Notable emphasis is placed on studies exploring the possible therapeutic relevance of bolstering brain endocannabinoid tone at different stages of alcohol use disorder.
内源性大麻素系统参与中枢神经系统的多种生理功能,包括调节大脑奖励回路和情绪稳态。大量证据表明,大脑内源性大麻素信号在药物诱导的奖励状态的处理中发挥作用,其中重复暴露会导致活动的病理性变化,从而促进酒精使用障碍的进展。本综述提供了一个叙述性总结,探讨了酒精暴露与内源性大麻素信号变化之间的相互作用,这些变化可能是酒精使用障碍发展的基础。
作者首先进行了一次初始检索,以协助确定相关文献。随后分别对主要文献和最新研究进行了搜索。搜索术语包括“酒精/乙醇”和“内源性大麻素”,以及涵盖强化和成瘾行为特定目标的术语。通过排除广泛关注精神疾病、多物质滥用、非大麻素信号脂质和其他标准的文章,进一步细化了内容。
最初的搜索在 PubMed 上共产生了 49 篇综述文章,在 ScienceDirect 上有 13 篇,在 Wiley Online 上有 17 篇,作者从中总共从 16 篇综述中获取了信息。除了独立搜索,本综述还提供了来自 212 篇出版物的信息,包括综述和原始研究文章。
综述讨论了酒精消费对大脑内源性大麻素信号的影响,包括酒精对内源性大麻素介导的突触传递的干扰、通过操纵内源性大麻素系统的信号元件来调节与酒精相关的行为,以及失调的内源性大麻素功能在促进戒断引起的焦虑样行为中的影响。特别强调了探索在不同阶段增强大脑内源性大麻素张力在治疗酒精使用障碍方面的可能治疗相关性的研究。